Logo image of SCVX

SCVX CORP - CLASS A (SCVX) Stock Fundamental Analysis

NYSEARCA:SCVX - NYSE Arca - Common Stock

9.92  +0.01 (+0.1%)

After market: 9.92 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SCVX. SCVX was compared to 0 industry peers in the Unkown industry. SCVX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SCVX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SCVX had positive earnings in the past year.
SCVX Yearly Net Income VS EBIT VS OCF VS FCFSCVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA 5.94%
ROE 6.68%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SCVX Yearly ROA, ROE, ROICSCVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 -5 -10

1.3 Margins

SCVX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SCVX Yearly Profit, Operating, Gross MarginsSCVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020

More info and screens

5

2. Health

2.1 Basic Checks

SCVX has more shares outstanding than it did 1 year ago.
There is no outstanding debt for SCVX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SCVX Yearly Shares OutstandingSCVX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 5M 10M 15M 20M 25M
SCVX Yearly Total Debt VS Total AssetsSCVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 6.45 indicates that SCVX is not in any danger for bankruptcy at the moment.
There is no outstanding debt for SCVX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.45
ROIC/WACCN/A
WACCN/A
SCVX Yearly LT Debt VS Equity VS FCFSCVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 50M 100M 150M

2.3 Liquidity

SCVX has a Current Ratio of 0.15. This is a bad value and indicates that SCVX is not financially healthy enough and could expect problems in meeting its short term obligations.
SCVX has a Quick Ratio of 0.15. This is a bad value and indicates that SCVX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.15
SCVX Yearly Current Assets VS Current LiabilitesSCVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 200K 400K 600K 800K 1M

More info and screens

0

3. Growth

3.1 Past

SCVX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57503.80%.
EPS 1Y (TTM)-57503.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2867.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SCVX Yearly Revenue VS EstimatesSCVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020
SCVX Yearly EPS VS EstimatesSCVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.11, the valuation of SCVX can be described as rather expensive.
SCVX is valuated rather cheaply when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.11
Fwd PE N/A
SCVX Price Earnings VS Forward Price EarningsSCVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SCVX Per share dataSCVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SCVX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCVX CORP - CLASS A

NYSEARCA:SCVX (3/8/2022, 8:26:04 PM)

After market: 9.92 0 (0%)

9.92

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)04-12 2022-04-12/amc
Inst Owners0.89%
Inst Owner Change0%
Ins Owners3.48%
Ins Owner Change0%
Market Cap285.20M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.11
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.39
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.47
EY4.74%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.15
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.94%
ROE 6.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.15
Quick Ratio 0.15
Altman-Z 6.45
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57503.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2867.47%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A